# US 2019/0316113 A1 · Method for Nucleic Acid Depletion

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316113 A1
- Document ID: US20190316113A1
- Status: Published application
- Kind: A1
- Application number: 16/468,922
- Filed: 2017-12-12
- Published: 2019-10-17
- Earliest claimed: 2016-12-14
- Assignees: UEA Enterprises Limited
- Applicants: UEA Enterprises Limited
- Inventors: Justin Joseph O'Grady; John Richard Wain; Solomon Mwaigwisya; Gemma Louise Kay
- Web page: https://patentgrep.com/patent/US20190316113A1

## CPC

- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Y 301/04003: Phospholipase C (3.1.4.3)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES

## Abstract

Provided is a method for depleting host nucleic acid in a biological sample, said sample having been previously obtained from an animal host, said method comprising the steps of (a) adding a cytolysin, or an active variant thereof, to said sample; and (b) carrying-out a process to physically deplete nucleic acid released from host cells within said sample or otherwise render such nucleic acid unidentifiable.

## Claims

### Claim 1

A method for depleting host nucleic acid in a biological sample, said sample having been previously obtained from an animal host, said method comprising the steps of:
(a) adding a cytolysin, or an active variant thereof, to said sample; and
(b) carrying-out a process to physically deplete nucleic acid released from host cells within said sample or otherwise render such nucleic acid unidentifiable.

### Claim 2 (depends on 1)

The method according to claim 1, wherein step (b) comprises adding a nuclease to said sample.

### Claim 3 (depends on 1)

The method according to claim 1, further comprising the step of extracting remaining nucleic acid from the sample.

### Claim 4 (depends on 3)

The method according to claim 3, further comprising the step of subjecting the extracted nucleic acid to a purification process.

### Claim 5 (depends on 3)

The method according to claim 3, further comprising the step of amplifying the extracted nucleic acid.

### Claim 6 (depends on 3)

The method according to claim 3, further comprising the step of conducting a nucleic acid amplification test on the extracted nucleic acid or conducting a sequencing process on the extracted nucleic acid.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the cytolysin is a phospholipase.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the phospholipase is a phospholipase C (PLC).

### Claim 9 (depends on 8)

The method according to claim 8, wherein the PLC is a bacterial PLC.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the bacterial PLC is a Group 1 PLC.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the Group 1 PLC is PLC from Clostridium perfringens.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the biological sample is a blood sample.

### Claim 13 (depends on 1)

The method according to claim 1, that results in at least a 10 fold, preferably at least a 102 fold, preferably at least a 103 fold, preferably at least a 104 fold, most preferably at least a 105 fold depletion of host DNA originally contained within the sample.

### Claim 14

A kit comprising i) a cytolysin, or an active variant thereof, and ii) a means to physically deplete free nucleic acid within a biological sample or otherwise render such nucleic acid unidentifiable.

### Claim 15 (depends on 14)

The kit according to claim 14, wherein said cytolysin is a phospholipase.

### Claim 16 (depends on 14)

The kit according to claim 14, wherein said means comprises a nuclease.
